BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang EA, Stein JP, Bellavia RJ, Broadwell SR. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. Int J Clin Pract 2017;71:e12972. [DOI: 10.1111/ijcp.12972] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Herman JM, Echeverry G, Russo S. Newer Cancer Therapies and Perioperative Implications. Perioperative Care of the Cancer Patient 2023. [DOI: 10.1016/b978-0-323-69584-8.00005-0] [Reference Citation Analysis]
2 Shukla J, Goyal A, Chhabra A, Rathore Y, Bansal K, Pandey S, Parmar M, Singhal S, Kalra N, Duseja A, Mittal BR. Cold kit for Rhenium-188 microspheres based selective intra-arterial therapy (SIRT): Preparation, characterization and feasibility study. Appl Radiat Isot 2022;190:110423. [PMID: 36183659 DOI: 10.1016/j.apradiso.2022.110423] [Reference Citation Analysis]
3 Van Laeken C, Taelman T, Cappuyns S, Maleux G, Vandecaveye V, Verslype C, Deroose C, Dekervel J. Clinical factors associated with early disease progression after radioembolization for hepatocellular carcinoma and feasibility of post‐progression systemic therapy. Liver Cancer International 2022;3:128-136. [DOI: 10.1002/lci2.60] [Reference Citation Analysis]
4 Oliván-sasot P, Pérez-enguix D, Bello-arques P, Torres-espallardo I, Falgás-lacueva M, Yepes-agudelo A, Olivas-arroyo C. Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases. Radiología (English Edition) 2022. [DOI: 10.1016/j.rxeng.2021.03.001] [Reference Citation Analysis]
5 Machida K, Tahara SM. Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells. Cancers (Basel) 2022;14:2381. [PMID: 35625986 DOI: 10.3390/cancers14102381] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fidani T, Desmarets G, Goupil J, Pouget JP, Boudousq V. A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall? Clin Nucl Med 2022. [PMID: 35353745 DOI: 10.1097/RLU.0000000000004133] [Reference Citation Analysis]
7 Yan Z, Da Q, Li Z, Lin Q, Yi J, Su Y, Yu G, Ren Q, Liu X, Lin Z, Qu J, Yin W, Liu J. Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis. Front Oncol 2022;12:812655. [PMID: 35223495 DOI: 10.3389/fonc.2022.812655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dong Y, Liu X, Jiang B, Wei S, Xiang B, Liao R, Wang Q, He X. A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma. Front Oncol 2021;11:780266. [PMID: 35111672 DOI: 10.3389/fonc.2021.780266] [Reference Citation Analysis]
9 Bertolet A, Wehrenberg-Klee E, Bobić M, Grassberger C, Perl J, Paganetti H, Schuemann J. Pre- and post-treatment image-based dosimetry in(90)Y-microsphere radioembolization using the TOPAS Monte Carlo toolkit. Phys Med Biol 2021;66. [PMID: 34915451 DOI: 10.1088/1361-6560/ac43fd] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ding Q, Lin D, Zhou Y, Li F, Lai J, Duan J, Chen J, Jiang C. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma. Oncol Lett 2021;22:857. [PMID: 34777591 DOI: 10.3892/ol.2021.13118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Cha Y, Wei Z, Ma C, Zhang L, Ramirez G. Intelligent Algorithm-Based Computed Tomography Image Features in Diagnosis of the Effect of Radiofrequency Ablation in Liver Cancer. Scientific Programming 2021;2021:1-9. [DOI: 10.1155/2021/3422484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Lu F, Ma XJ, Jin WL, Luo Y, Li X. Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges. Front Immunol 2021;12:690565. [PMID: 34054880 DOI: 10.3389/fimmu.2021.690565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Van Thai N, Thinh NT, Ky TD, Bang MH, Giang DT, Ha LN, Son MH, Tien DD, Lee HW. Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma. BMC Gastroenterol 2021;21:216. [PMID: 33980171 DOI: 10.1186/s12876-021-01805-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lotter K, Diemling M, Sohlberg A, Wiedner H, Haug A, Maringer FJ. Comparing calculated and experimental activity and dose values obtained from image-based quantification of 90Y SPECT/CT Data. Z Med Phys 2021:S0939-3889(21)00033-7. [PMID: 33966943 DOI: 10.1016/j.zemedi.2021.03.005] [Reference Citation Analysis]
15 Sun G, Sun K, Shen C. Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients. World J Surg Oncol 2021;19:137. [PMID: 33941198 DOI: 10.1186/s12957-021-02246-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Guo J, Guo M, Zheng J. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway. Cancer Manag Res 2021;13:773-85. [PMID: 33536785 DOI: 10.2147/CMAR.S281969] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Tagliaferri L, D’aviero A, Posa A, Iezzi R. Interventional Image-Guided HDR Brachytherapy as a Salvage Treatment: Exclusive or in Combination with Other Local Therapies. Manual on Image-Guided Brachytherapy of Inner Organs 2021. [DOI: 10.1007/978-3-030-78079-1_16] [Reference Citation Analysis]
18 Shehta A, Lee JM, Suh KS, Kim HC, Hong SK, Cho JH, Yi NJ, Lee KW. Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg 2020;24:421-30. [PMID: 33234744 DOI: 10.14701/ahbps.2020.24.4.421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Auditore L, Amato E, Boughdad S, Meyer M, Testart N, Cicone F, Beigelman-Aubry C, Prior JO, Schaefer N, Gnesin S. Monte Carlo 90Y PET/CT dosimetry of unexpected focal radiation-induced lung damage after hepatic radioembolisation. Phys Med Biol 2020;65:235014. [PMID: 33245055 DOI: 10.1088/1361-6560/abbc80] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 D’arienzo M, Sarnelli A, Mezzenga E, Chiacchiararelli L, Amato A, Romanelli M, Cianni R, Cremonesi M, Paganelli G. Dosimetric Issues Associated with Percutaneous Ablation of Small Liver Lesions with 90Y. Applied Sciences 2020;10:6605. [DOI: 10.3390/app10186605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lee JM, Lee KW, Kim HC, Yi NJ, Suh KS. No touch isolation technique for the prevention of postoperative recurrence of hepatocellular carcinoma after liver transplantation-combined with trans-arterial radioembolization. Surg Oncol 2020;35:189-90. [PMID: 32890956 DOI: 10.1016/j.suronc.2020.08.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Pang F, Li Y, Zhang W, Xia C, He Q, Li Z, Xiao L, Song S, Dong P, Zhou H, Shao T, Cai H, Li L. Biodegradable 131 Iodine-Labeled Microspheres: Potential Transarterial Radioembolization Biomaterial for Primary Hepatocellular Carcinoma Treatment. Adv Healthc Mater 2020;9:e2000028. [PMID: 32431090 DOI: 10.1002/adhm.202000028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Liu Y, Tan M, Zhang Y, Huang W, Min L, Peng S, Yuan K, Qiu L, Min W. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem. Nanoscale Res Lett 2020;15:116. [PMID: 32449085 DOI: 10.1186/s11671-020-03340-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Zhang Y, Ding M, Chi JC, Wang T, Shi YP, Zhai B. The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinoma. Brachytherapy 2019;18:733-9. [PMID: 31515049 DOI: 10.1016/j.brachy.2019.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Gholami YH, Josephson L, Akam EA, Caravan P, Wilks MQ, Pan XZ, Maschmeyer R, Kolnick A, El Fakhri G, Normandin MD, Kuncic Z, Yuan H. A Chelate-Free Nano-Platform for Incorporation of Diagnostic and Therapeutic Isotopes. Int J Nanomedicine 2020;15:31-47. [PMID: 32021163 DOI: 10.2147/IJN.S227931] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
26 Inchingolo R, Posa A, Mariappan M, Spiliopoulos S. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. World J Gastroenterol 2019;25:4614-28. [PMID: 31528090 DOI: 10.3748/wjg.v25.i32.4614] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
27 Wang YG, Wang T, Shi M, Zhai B. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. J Exp Clin Cancer Res 2019;38:153. [PMID: 30971290 DOI: 10.1186/s13046-019-1128-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
28 Shih Y, Peng C, Weng M, Chiang P, Luo T, Lin X. Evaluation Efficacy of Rhenium-188-Loaded Micro-particles for Radiotherapy in a Mouse Model of Hepatocellular Carcinoma. Mol Pharmaceutics 2019;16:1083-91. [DOI: 10.1021/acs.molpharmaceut.8b01083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Carrick K, Zheng W. Secondary Tumors of the Ovary. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_10] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Grzmil M, Meisel A, Behé M, Schibli R. An Overview of Targeted Radiotherapy. Radiopharmaceutical Chemistry 2019. [DOI: 10.1007/978-3-319-98947-1_5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Pan C, Xiang L, Pan Z, Wang X, Li J, Zhuge L, Fang P, Xie Q, Hu X. MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer. Cancer Cell Int 2018;18:52. [PMID: 29636640 DOI: 10.1186/s12935-018-0542-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]